Take Solutions (TAKE) — Board Meeting

📢 Key Event
Board approved Q1 FY27 financial results and strategic entry into longevity market

🔄 What Changed
Consolidated net profit turned positive at ₹1.06 crores from prior-year loss; finance costs dropped 99.6% to ₹0.07 lakhs

🔮 What's Next
Strategic entry into India's longevity and anti-aging market with high-margin, recurring revenue model

💡 Investor Takeaway
Profitability restored with clean balance sheet and new growth avenue in high-potential wellness sector

TAKE Limited announced the outcome of its August 11, 2026 board meeting, approving unaudited Q1 FY27 standalone and consolidated financial results showing consolidated revenue of ₹30.37 crores and net profit of ₹1.06 crores, reversing a prior-year loss. The board also endorsed the company's strategic entry into biohacking, science-backed nutraceuticals, and digital longevity solutions targeting India's growing preventive healthcare market.

📄 View Original Announcement (PDF)

📊 Stock Analysis — TAKE ✨ Ask AI About This

About Take Solutions Limited (TAKE)

Healthcare · Healthcare · Listed on NSE

Market Cap: ₹217.46 Cr P/E: 17.1 ROE: 62.5% ROCE: 30.4%

View full TAKE stock details →

📡 Get AI alerts when TAKE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track TAKE — Free

💡 Ask AI about this filing

"How does the longevity market strategy impact future revenue growth?" "What is the projected timeline for commercializing biohacking products?" "How will the company maintain zero finance costs long-term?"

Ask AI Free →

📊 More TAKE filings

See all TAKE filings →

🔥 Also filed on 11 August 2026

ULTRACEMCO UltraTech Cement Limited Announcement SUDEEPPHRM Sudeep Pharma Limited Financial Results SUTLEJTEX Sutlej Textiles and Industries Limited Financial Results RBZJEWEL RBZ Jewellers Limited Financial Results TATVA Tatva Chintan Pharma Chem Limited Corporate Action AETHER Aether Industries Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when TAKE files new disclosures

Track TAKE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track TAKE — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd